Solesence, Inc. Common Stock (SLSN)
Automate Your Wheel Strategy on SLSN
With Tiblio's Option Bot, you can configure your own wheel strategy including SLSN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SLSN
- Rev/Share 0.8146
- Book/Share 0.2162
- PB 22.2484
- Debt/Equity 1.4883
- CurrentRatio 1.0921
- ROIC 0.1057
- MktCap 337196854.0
- FreeCF/Share -0.0837
- PFCF -57.4637
- PE 98.5091
- Debt/Assets 0.3956
- DivYield 0
- ROE 0.2394
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Solésence Expands Debt Facilities to Fuel Growth Initiatives
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its existing loan agreements, providing increased borrowing capacity to support the execution of strategic objectives.
Read More
Solesence, Inc. (SLSN) Q1 2025 Earnings Conference Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Solesence, Inc. (NASDAQ:SLSN ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Jess Jankowski - President & CEO Kevin Cureton - COO Conference Call Participants Operator Good day and thank you for standing by. Welcome to the Solesence First Quarter 2025 Conference Call.
Read More
About Solesence, Inc. Common Stock (SLSN)
- IPO Date 2025-04-08
- Website https://solesence.com
- Industry Household & Personal Products
- CEO Jess A. Jankowski
- Employees 98